Feb 12 2018 17:30
If you have an idea but you don’t know where to start or if you are interested in entrepreneurship, this is a must-attend event for you!
Time: 5:30 pm on 12th February
Venue: Main Seminar Room, New Biochemistry, south Parks road
In this event, participants will have the opportunity to engage in a science innovation workshop.
Speakers will present their experiences as either successful science entrepreneurs or investors, giving valuable tips on how to make the transition from a good idea to building a start-up and securing investment. At the end, participants will have the chance to take part in a “hands-on” activity and interact with our experienced speakers. Limited spots available.
There will be a networking & drinks reception after the event!
As always, this event is free and everyone is welcome!
About the speakers:
Lachlan is an investor at Oxford Sciences Innovation, a £600m fund launched in 2015 to back IP driven business originating from University of Oxford research. Lachlan studied Chemistry at Oxford before joining OSI and has made 6 investments in technologies at the intersection of physical and life sciences, including ONI and Spybiotech.
Dr Michalis Papadakis is a co-founder and the CEO of Brainomix, an award winning University of Oxford spin-out. Building the company from the ground up he has significant experience in start-ups and innovation. He has led the development, regulatory clearance and commercialisation of medical imaging, decision support tools for stroke diagnosis and treatment. He has secured and managed more than £1.5 million of Innovate UK funding and £2.7 million of private investment. He has a BSc Honours in Biochemistry from Imperial College and a PhD in Neurosciences from UCL School of Pharmacy. In 2005, he joined the Laboratory of Cerebral Ischaemia at the University of Oxford where he was the scientific director. He has been an invited speaker at international stroke conferences and has more than 25 publications in the field of cerebral ischemia and translational stroke research studies.